中西医结合治疗肝硬化合并上消化道出血临床观察

发布时间：2019-07-25 14:49

【摘要】：目的:探讨中西医结合治疗肝硬化合并上消化道出血的临床效果。方法:选取2014年3月—2016年8月收治的肝硬化合并上消化道出血的患者96例为研究对象,随机分为治疗组与对照组,对照组患者单纯给予奥曲肽治疗,治疗组患者给予奥曲肽联合止血散和清肠汤治疗,对比两组患者的临床疗效、输血量、止血时间、住院时间,并观察两组患者不良反应发生情况。结果:治疗组、对照组的总有效率分别为93.75%、81.25%,与对照组对比,治疗组的总有效率明显升高(P0.05);与对照组对比,治疗组患者的输血量明显减少,止血时间与住院时间明显缩短(P0.05);两组患者不良反应的总发生率对比无显著差异(P0.05)。结论:在奥曲肽治疗的基础上联合止血散和清肠汤治疗可显著提高临床疗效,缩短治疗时间,值得临床推广应用。
[Abstract]:Objective: to investigate the clinical effect of integrated traditional Chinese and western medicine in the treatment of liver cirrhosis complicated with upper gastrointestinal bleeding. Methods: from March 2014 to August 2016, 96 patients with liver cirrhosis complicated with upper gastrointestinal bleeding were randomly divided into treatment group and control group. The patients in the control group were treated with octreotide alone, and the patients in the treatment group were treated with octreotide combined with Zhixue Powder and Qingchang decoction. The clinical efficacy, transfusion volume, hemostatic time and hospitalization time of the two groups were compared, and the occurrence of adverse reactions in the two groups was observed. Results: the total effective rate of the treatment group and the control group was 93.75% and 82.5% respectively. compared with the control group, the total effective rate of the treatment group was significantly higher than that of the control group (P 0.05). Compared with the control group, the blood transfusion volume of the treatment group was significantly reduced, and the hemostatic time and hospitalization time were significantly shortened (P0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P 0.05). Conclusion: the treatment of octreotide combined with Zhixue Powder and Qingchang decoction can significantly improve the clinical curative effect and shorten the treatment time, which is worth popularizing and applying in clinic.
【作者单位】：青海省第四人民医院肝一科;
【基金】：青海省(应用)基础研究计划项目(2014-ZJ-757)
【分类号】：R573.2;R575.2

【相似文献】